(Q42693836)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21392103%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

title

Response to atomoxetine in boys with high-functioning autism spectrum disorders and attention deficit/hyperactivity disorder (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21392103%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

main subject

autism spectrum disorder

0 references

autism

0 references

high-functioning autism

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21392103%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

author name string

Pål Zeiner

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21392103%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

Elen Gjevik

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21392103%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

language of work or name

English

0 references

publication date

6 April 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21392103%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21392103%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

volume

100

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21392103%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21392103%20AND%20SRC:MED&resulttype=core&format=json

25 January 2020

page(s)

1258-1261

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21392103%20AND%20SRC:MED&resulttype=core&format=json

Psychiatric disorders in children with autism spectrum disorders: prevalence, comorbidity, and associated factors in a population-derived sample

25 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2011.02263.X

Comorbid psychiatric disorders associated with Asperger syndrome/high-functioning autism: a community- and clinic-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2011.02263.X

Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2011.02263.X

Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2011.02263.X

Acute atomoxetine treatment of younger and older children with ADHD: a meta-analysis of tolerability and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2011.02263.X

Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2011.02263.X

Retrospective assessment of atomoxetine in children and adolescents with pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2011.02263.X

Open-label atomoxetine for attention-deficit/ hyperactivity disorder symptoms associated with high-functioning pervasive developmental disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2011.02263.X

Atomoxetine for attention-deficit/hyperactivity disorder symptoms in children with pervasive developmental disorders: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2011.02263.X

Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2011.02263.X

ADHD Rating Scale IV: psychometric properties from a multinational study as a clinician-administered instrument.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2011.02263.X

The Strengths and Difficulties Questionnaire: a research note

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2011.02263.X

Atomoxetine and osmotically released methylphenidate for the treatment of attention deficit hyperactivity disorder: acute comparison and differential response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1651-2227.2011.02263.X